alexa Pallav D. Patel | Memorial Sloan-Kettering Cancer Cente
ISSN: 2169-0138

Drug Designing: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Pallav D. Patel

Pallav D. Patel Pallav D. Patel
Memorial Sloan-Kettering Cancer Center
New York, USA
Biography

Dr. Patel is a dynamic research professional at Memorial Sloan Kettering Cancer Center with an active interest in discovering novel anticancer agents. He is an author of over a dozen publications in peer reviewed journals -- Nature Chemical Biology and Cell-Chemistry & Biology amongst others. Dr. Patel’s work was featured on the Cell-Chemistry & Biology Journal cover (December 2013), highlighted in Cancer Discovery’s Research Watch (October 2013) and admired in Nature Science-Business eXchange (October 2013). He wrote grant proposals which resulted in NIH Exploratory and Developmental Research Grant Awards and has presented his findings at several National and International conferences. Dr. Patel’s research efforts resulted in to two PCT-Patent Applications and one US-Provisional Patent Application claiming composition of matter for anticancer treatment. He also serves as a Scientific Advisor at a patent law firm and is on the Editorial Board and Referee of 12 renowned scientific journals. Dr. Patel received his Ph.D, Masters and training in Pharmaceutical Sciences at Memorial Sloan Kettering Cancer Center, St. John’s University and Synta Pharmaceuticals (NASDAQ: SNTA).

Research Interest

Dr. Patel’s research interests are in the design, synthesis and development of novel anticancer drug molecules using a combined Medicinal Chemistry, Computational Chemistry and Biology approach. He is actively involved in various aspects of preclinical and clinical drug discovery process and has contributed significantly to the discovery and development of selective inhibitors of Grp94, one of the four Hsp90 family paralog, which is of high therapeutic relevance in HER2++ breast cancer. The compounds derived from his work are truly the first selective Grp94 inhibitors that would prevent any foreseen toxicity of non selective Hsp90 inhibitors -- currently in clinical trials.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords